Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “glucagon”

23 pharma patents match "glucagon" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 23
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 23 pharmaceutical patents matching "glucagon" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

23 results for “glucagon” · 30,257 patents in full index Clear search

  1. WO 2025252715

    AGONISTE DOUBLE DU RÉCEPTEUR DU GLP-1 ET DU GLUCAGON POUR LE TRAITEMENT DE LA MASH ET DE LA CIRRHOSE

    BOEHRINGER INGELHEIM INT [DE] · Granted Dec 11, 2025 · Expires Dec 6, 2045

    granted
  2. US 12421317

    Polynucleotides encoding anti-glucagon-like peptide 1 receptor (GLP1R) antagonist antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  3. US 12269889

    Human antibodies to the human glucagon receptor (HGCGR) and methods of use thereof to lower blood glucose or ketone levels

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted
  4. US 12208071

    Glucagon receptor antagonists

    Ligand Pharmaceuticals Incorporated · Granted Jan 28, 2025 · Expires Jan 23, 2045

    granted
  5. US 12139546

    Methods of treating urea cycle disorders by interfering with glucagon receptor signaling

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 12, 2024 · Expires Nov 7, 2044

    granted
  6. US 12090193

    Glucagon-like peptide 1 receptor agonists and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted
  7. US 11951176

    Stabilization of glucagon by trehalose glycopolymer nanogels

    The Regents of the University of California · Granted Apr 9, 2024 · Expires Apr 4, 2044

    granted
  8. US 11884736

    Antibodies which bind to glucagon-like peptide 1 receptor (GLP1R)

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted
  9. US 11779633

    Glucagon-like peptide 1 receptor agonists and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted
  10. US 11708416

    Methods of treating severe insulin resistance by interfering with glucagon receptor signaling

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  11. US 11590205

    Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents

    XERIS PHARMACEUTICALS, INC. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  12. US 11498970

    Human antibodies to the human glucagon receptor and methods of use thereof to lower blood glucose or ketone levels

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 15, 2022 · Expires Nov 10, 2042

    granted
  13. US 11045522

    Glucagon-like peptide 1 receptor agonists and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  14. US 10995146

    Methods of treating severe insulin resistance by interfering with glucagon receptor signaling

    REGENERON PHARMACEUTICALS, INC. · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  15. US 10640566

    Nucleic acid molecules encoding antibodies to the human glucagon receptor

    REGENERON PHARMACEUTICALS, INC. · Granted May 5, 2020 · Expires Apr 30, 2040

    granted
  16. US 10233250

    Human antibodies to the glucagon receptor and methods of use thereof for lowering blood glucose or ketone levels

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  17. US 9687527

    Stable glucagon formulations for the treatment of hypoglycemia

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 27, 2017 · Expires Jun 22, 2037

    granted
  18. US 9657099

    Anti-glucagon antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted May 23, 2017 · Expires May 18, 2037

    granted
  19. US 9587029

    Human antibodies to the glucagon receptor and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  20. US 9358287

    Method of treating stress hyperglycemia with human antibodies to the glucagon receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  21. US 9127068

    Nucleic acids encoding human glucagon receptor antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  22. US 8771696

    Method of reducing the severity of stress hyperglycemia with human antibodies to the glucagon receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  23. US 8545847

    Human antibodies to the human glucagon receptor and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted